Boosting with Maraba virus expressing the human melanoma antigen dopachrome tautomerase (DCT) generated robust tumor-specific CD8+ T cell responses resulting in improved tumor control and unique immunological changes in tumors. This evidence concerns the gene CD8A and melanoma.